{"id":476589,"date":"2021-04-15T06:33:22","date_gmt":"2021-04-15T10:33:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/"},"modified":"2021-04-15T06:33:22","modified_gmt":"2021-04-15T10:33:22","slug":"emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/","title":{"rendered":"Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">GAITHERSBURG, Md., April  15, 2021  (GLOBE NEWSWIRE) &#8212; Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, April 29, 2021 at 5:00 pm eastern time to discuss the financial results for the first quarter of 2021, recent business developments, revenue guidance for the second quarter of 2021, and financial outlook for full year 2021.<\/p>\n<p>This conference call can be accessed live by telephone or by webcast:<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:4%;width:4%;min-width:4%;vertical-align: top\">\u00a0<\/td>\n<td style=\"max-width:96%;width:96%;min-width:96%;vertical-align: top\">\n            <strong><br \/>\n              <u>Teleconference Information<\/u><br \/>\n            <\/strong><br \/>\n            <strong>:<\/strong><br \/>\n            <br \/>Dial in number \u2013 toll-free: <strong>(855) 766-6521<\/strong><br \/>Dial in number \u2013 toll: (262) 912-6157<br \/>Conference ID: <strong>9153099<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td style=\"vertical-align: top\">\n            <strong><br \/>\n              <u>Webcast Information<\/u><br \/>\n            <\/strong><br \/>\n            <strong>:<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td style=\"vertical-align: top\">Visit <a href=\"https:\/\/edge.media-server.com\/mmc\/p\/yvrb3cpe\" rel=\"nofollow noopener\" target=\"_blank\"><u>https:\/\/edge.media-server.com\/mmc\/p\/yvrb3cpe<\/u><\/a> for the live webcast.<\/td>\n<\/tr>\n<\/table>\n<p>A replay of the call can be accessed from the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3wJeemGU7SSQHQVvuB-nczUGtaWputmI_lSLC5UC2Zu6qW80XbJYuLJX56z2XfAglhuEor3haEwp6azqvEHVjXDAVj-QGUFzp8k9l9wFiOG6m0VJw95MRETenOr5HNHb\" rel=\"nofollow noopener\" target=\"_blank\">Emergent website<\/a>.<\/p>\n<p>\n        <strong>About Emergent BioSolutions<\/strong><br \/>\n        <br \/>Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what\u2019s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information, visit our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aIy00hOQHxudc0tYar9uk7cxDGQl5KALLW07Skjx7yJXSgUOztuWjj_xRa1PdJHzJdoIJGOAnLH0uEz3brF9TQ==\" rel=\"nofollow noopener\" target=\"_blank\">website<\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OxRFdP-hakfonoaAnlNEqE1dE5ByQzq8OKfqtJ6HPcKfyPmcA3wu9IbBe_NlAx2lshwqZiiuoT56etqvUhHLyCqFVa3l7oQsC36sbQSc0z9DvOOVL8z7XhEvDCmmY2yA\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BQnDkSs-ZULe05AidNpOABG2Fb9Dxcmufj7DrOP7aTkYDL65So6ymjPZFd0wU00c8k0OuiAvm8Ute7Jixn6heg==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>, and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QJ9rRsPSdSBff-G1zjVtk9G6aNGqq0XXYJNK5c9fEo7owrMUJo5gjQMWPQ702qOZqCMwn9n9o6WAeCcvreqxWQ6fMUtFKz1c7h0hgGMw1JE=\" rel=\"nofollow noopener\" target=\"_blank\">Instagram<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Robert G. Burrows<br \/>Vice President, Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IPUqos0W3T9eSfJiR1jkWfLg2gMsLlnAT9not0F07eKcuwCJyM0gHFcnHYwobZOWGWr-HdvMCpZIq-xP8IGU4w==\" rel=\"nofollow noopener\" target=\"_blank\"><u>burrowsr@ebsi.com<\/u><\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Matt Hartwig<br \/>Director, Media Relations<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-83ho8r6_Ku0_DHF0KYv3wOanKoRbZvzahq5cj2qw8_emlFnIzG333G_ETWDUO6Mhbu5raaPvt74hr1uLu-JUx74EiCySPkXVzZceOgt5oM=\" rel=\"nofollow noopener\" target=\"_blank\">mediarelations@ebsi.com<\/a><\/u><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNzI2OCM0MTIxODk5IzIwMTA4NjY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/9fe2b545-abb6-4a3b-8958-eeb44c8dd80e\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>GAITHERSBURG, Md., April 15, 2021 (GLOBE NEWSWIRE) &#8212; Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, April 29, 2021 at 5:00 pm eastern time to discuss the financial results for the first quarter of 2021, recent business developments, revenue guidance for the second quarter of 2021, and financial outlook for full year 2021. This conference call can be accessed live by telephone or by webcast: \u00a0 Teleconference Information : Dial in number \u2013 toll-free: (855) 766-6521Dial in number \u2013 toll: (262) 912-6157Conference ID: 9153099 \u00a0 \u00a0 \u00a0 Webcast Information : \u00a0 Visit https:\/\/edge.media-server.com\/mmc\/p\/yvrb3cpe for the live webcast. A replay of the call can be accessed from the Emergent website. About Emergent BioSolutions Emergent BioSolutions is a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-476589","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GAITHERSBURG, Md., April 15, 2021 (GLOBE NEWSWIRE) &#8212; Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, April 29, 2021 at 5:00 pm eastern time to discuss the financial results for the first quarter of 2021, recent business developments, revenue guidance for the second quarter of 2021, and financial outlook for full year 2021. This conference call can be accessed live by telephone or by webcast: \u00a0 Teleconference Information : Dial in number \u2013 toll-free: (855) 766-6521Dial in number \u2013 toll: (262) 912-6157Conference ID: 9153099 \u00a0 \u00a0 \u00a0 Webcast Information : \u00a0 Visit https:\/\/edge.media-server.com\/mmc\/p\/yvrb3cpe for the live webcast. A replay of the call can be accessed from the Emergent website. About Emergent BioSolutions Emergent BioSolutions is a &hellip; Continue reading &quot;Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-15T10:33:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNzI2OCM0MTIxODk5IzIwMTA4NjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021\",\"datePublished\":\"2021-04-15T10:33:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\\\/\"},\"wordCount\":237,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxNzI2OCM0MTIxODk5IzIwMTA4NjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\\\/\",\"name\":\"Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxNzI2OCM0MTIxODk5IzIwMTA4NjY=\",\"datePublished\":\"2021-04-15T10:33:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxNzI2OCM0MTIxODk5IzIwMTA4NjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxNzI2OCM0MTIxODk5IzIwMTA4NjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/","og_locale":"en_US","og_type":"article","og_title":"Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021 - Market Newsdesk","og_description":"GAITHERSBURG, Md., April 15, 2021 (GLOBE NEWSWIRE) &#8212; Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, April 29, 2021 at 5:00 pm eastern time to discuss the financial results for the first quarter of 2021, recent business developments, revenue guidance for the second quarter of 2021, and financial outlook for full year 2021. This conference call can be accessed live by telephone or by webcast: \u00a0 Teleconference Information : Dial in number \u2013 toll-free: (855) 766-6521Dial in number \u2013 toll: (262) 912-6157Conference ID: 9153099 \u00a0 \u00a0 \u00a0 Webcast Information : \u00a0 Visit https:\/\/edge.media-server.com\/mmc\/p\/yvrb3cpe for the live webcast. A replay of the call can be accessed from the Emergent website. About Emergent BioSolutions Emergent BioSolutions is a &hellip; Continue reading \"Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-15T10:33:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNzI2OCM0MTIxODk5IzIwMTA4NjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021","datePublished":"2021-04-15T10:33:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/"},"wordCount":237,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNzI2OCM0MTIxODk5IzIwMTA4NjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/","name":"Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNzI2OCM0MTIxODk5IzIwMTA4NjY=","datePublished":"2021-04-15T10:33:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNzI2OCM0MTIxODk5IzIwMTA4NjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNzI2OCM0MTIxODk5IzIwMTA4NjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-first-quarter-2021-financial-results-and-conduct-a-conference-call-on-april-29-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/476589","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=476589"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/476589\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=476589"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=476589"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=476589"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}